Marguerite Koutsoukos Selected Research

Marguerite Koutsoukos Research Topics

10	Infections 01/2023 - 08/2005
7	COVID-19 11/2023 - 01/2022
4	HIV Infections (HIV Infection) 01/2022 - 04/2011
2	Virus Diseases (Viral Diseases) 03/2021 - 01/2021
2	Vaccinia 01/2020 - 01/2020
2	Measles 12/2013 - 12/2012
2	Tuberculosis (Tuberculoses) 11/2010 - 07/2009
1	Injection Site Reaction 11/2023
1	Fever (Fevers) 01/2020
1	Pain (Aches) 01/2020
1	Angioedema 02/2016
1	Viremia 12/2012
1	HIV Seropositivity 04/2011
1	Hypersensitivity (Allergy) 03/2008
1	Malaria 03/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2007

26	VaccinesIBA 11/2023 - 08/2005
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2011
2	Combined VaccinesIBA 11/2023 - 01/2023
2	Neutralizing AntibodiesIBA 01/2022 - 08/2005
2	AIDS VaccinesIBA 01/2021 - 04/2011
2	AIDSVAXIBA 01/2021 - 01/2018
2	AntigensIBA 05/2016 - 03/2008
1	Nucleic AcidsIBA 11/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	env Gene ProductsIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	AIDSVAX B-EIBA 01/2021
1	Immunoglobulin G (IgG)IBA 11/2020
1	W-135 and Y tetanus toxoid conjugate vaccine C tetravalent meningococcal serogroups AIBA 01/2020
1	MF59 oil emulsionIBA 01/2018
1	Broadly Neutralizing AntibodiesIBA 11/2017
1	Therapeutic UsesIBA 05/2014
1	Viral RNAIBA 12/2012
1	Protein Subunits (Protein Subunit)IBA 01/2012
1	PolyproteinsIBA 04/2011
1	AntibodiesIBA 04/2011
1	RTS malaria vaccineIBA 03/2007
1	Recombinant ProteinsIBA 01/2007
1	Indicators and Reagents (Reagents)IBA 08/2005

1	Contraindications 10/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Intramuscular Injections 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 01/2012